Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The parasite calcium influx mechanisms, specifically the tegumental calcium channels, are critical components of the physiological machinery in parasitic flatworms such as Schistosoma mansoni. These channels regulate the entry of calcium ions into the parasite's syncytial tegument and underlying musculature, which is essential for maintaining neuromuscular tone and tegumental integrity (Greenberg, 2005). While historically associated with voltage-gated calcium channel (VGCC) subunits, recent research has identified a specific transient receptor potential (TRP) channel, termed SmTRPMPZQ, as the definitive target for the anthelmintic drug Praziquantel (Park et al., 2019). Activation of this channel by Praziquantel triggers a rapid and massive influx of calcium, leading to immediate spastic paralysis and severe vacuolization of the parasite's tegument. This disruption exposes parasite-specific antigens to the host's immune system, facilitating the clearance of the infection (Park et al., 2019). The channel is characterized by its unique sensitivity to Praziquantel, a feature not shared by mammalian TRP homologs, which provides a high therapeutic index. However, the lack of efficacy against juvenile schistosomes remains a significant clinical challenge, as these stages appear to have different calcium regulation requirements or lower channel expression. Understanding these mechanisms is vital for addressing emerging drug resistance and developing next-generation anthelmintics.
Agonist-induced activation of the channel leading to rapid calcium influx, resulting in sustained muscle contraction and tegumental damage.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transient receptor potential channel Melastatin-like (TRPMPZQ) (TRPMPZQ).